AAAAAA
Results: 1-25/27
Authors:
Glick, ID
Janowsky, DS
Zisook, S
Lydiard, RB
Oesterheld, JR
Ward, NG
Ellison, J
Halper, J
Doraiswamy, PM
Preven, DW
Ross, R
Klein, DE
Citation: Id. Glick et al., How should we teach psychopharmacology to residents? Results of the initial experience with the ASCP model Curriculum, ACAD PSYCHI, 25(2), 2001, pp. 90-97
Authors:
Miller, HL
Ekstrom, RD
Mason, GA
Lydiard, RB
Golden, RN
Citation: Hl. Miller et al., Noradrenergic function and clinical outcome in antidepressant pharmacotherapy, NEUROPSYCH, 24(6), 2001, pp. 617-623
Authors:
Labbate, LA
Brodrick, PS
Nelson, RP
Lydiard, RB
Arana, GW
Citation: La. Labbate et al., Effects of bupropion sustained-release on sexual functioning and nocturnalerections in healthy men, J CL PSYCH, 21(1), 2001, pp. 99-103
Authors:
Thase, ME
Feighner, JP
Lydiard, RB
Citation: Me. Thase et al., Citalopram treatment of fluoxetine nonresponders, J CLIN PSY, 62(9), 2001, pp. 683-687
Authors:
Ballenger, JC
Davidson, JRT
Lecrubier, Y
Nutt, DJ
Lydiard, RB
Mayer, EA
Citation: Jc. Ballenger et al., Consensus statement on depression, anxiety, and functional gastrointestinal disorders, J CLIN PSY, 62, 2001, pp. 48-51
Authors:
Lydiard, RB
Citation: Rb. Lydiard, Social anxiety disorder: Comorbidity and its implications, J CLIN PSY, 62, 2001, pp. 17-24
Authors:
Shelton, RC
Keller, MB
Gelenberg, A
Dunner, DL
Hirschfeld, R
Thase, ME
Russell, J
Lydiard, RB
Crits-Cristoph, P
Gallop, R
Todd, L
Hellerstein, D
Goodnick, P
Keitner, G
Stahl, SM
Halbreich, U
Citation: Rc. Shelton et al., Effectiveness of St John's Wort in major depression - A randomized controlled trial, J AM MED A, 285(15), 2001, pp. 1978-1986
Authors:
Eisen, JL
Rasmussen, SA
Phillips, KA
Price, LH
Davidson, J
Lydiard, RB
Ninan, P
Piggott, T
Citation: Jl. Eisen et al., Insight and treatment outcome in obsessive-compulsive disorder, COMP PSYCHI, 42(6), 2001, pp. 494-497
Authors:
Emmanuel, NP
Brawman-Mintzer, O
Morton, WA
Book, SW
Johnson, MR
Lorberbaum, JP
Ballenger, JC
Lydiard, RB
Citation: Np. Emmanuel et al., Bupropion-SR in treatment of social phobia, DEPRESS ANX, 12(2), 2000, pp. 111-113
Authors:
Lydiard, RB
Bobes, J
Citation: Rb. Lydiard et J. Bobes, Therapeutic advances: Paroxetine for the treatment of social anxiety disorder, DEPRESS ANX, 11(3), 2000, pp. 99-104
Authors:
Villarreal, G
Johnson, MR
Rubey, R
Lydiard, RB
Ballanger, JC
Citation: G. Villarreal et al., Treatment of social phobia with the dopamine agonist pergolide, DEPRESS ANX, 11(1), 2000, pp. 45-47
Authors:
Uhlenhuth, EH
Matuzas, W
Warner, TD
Paine, S
Lydiard, RB
Pollack, MH
Citation: Eh. Uhlenhuth et al., Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication, J CL PSYCH, 20(6), 2000, pp. 622-627
Authors:
Pande, AC
Pollack, MH
Crockatt, J
Greiner, M
Chouinard, G
Lydiard, RB
Taylor, CB
Dager, SR
Shiovitz, T
Citation: Ac. Pande et al., Placebo-controlled study of gabapentin treatment of panic disorder, J CL PSYCH, 20(4), 2000, pp. 467-471
Authors:
Brunello, N
den Boer, JA
Judd, LL
Kasper, S
Kelsey, JE
Lader, M
Lecrubier, Y
Lepine, JP
Lydiard, RB
Mendlewicz, J
Montgomery, SA
Racagni, G
Stein, MB
Wittchen, HU
Citation: N. Brunello et al., Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment, J AFFECT D, 60(1), 2000, pp. 61-74
Authors:
Lydiard, RB
Citation: Rb. Lydiard, An overview of generalized anxiety disorder: Disease state-appropriate therapy, CLIN THER, 22, 2000, pp. A3-A19
Authors:
Gelenberg, AJ
Lydiard, RB
Rudolph, RL
Aguiar, L
Haskins, JT
Salinas, E
Citation: Aj. Gelenberg et al., Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder - A 6-month randomized controlled trial, J AM MED A, 283(23), 2000, pp. 3082-3088
Authors:
Goldstein, G
Fava, M
Culler, M
Fisher, A
Rickels, K
Lydiard, RB
Rosenbaum, J
Citation: G. Goldstein et al., Elevated plasma thymopoietin associated with therapeutic nonresponsivenessin major depression, BIOL PSYCHI, 48(1), 2000, pp. 65-69
Authors:
Lorberbaum, JP
Newman, JD
Dubno, JR
Horwitz, AR
Nahas, Z
Teneback, CC
Bloomer, CW
Bohning, DE
Vincent, D
Johnson, MR
Emmanuel, N
Brawman-Mintzer, O
Book, SW
Lydiard, RB
Ballenger, JC
George, MS
Citation: Jp. Lorberbaum et al., Feasibility of using fMRI to study mothers responding to infant cries, DEPRESS ANX, 10(3), 1999, pp. 99-104
Authors:
DeVane, CL
Ware, MR
Emmanuel, NP
Brawman-Mintzer, O
Morton, WA
Villarreal, G
Lydiard, RB
Citation: Cl. Devane et al., Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia, INT CLIN PS, 14(6), 1999, pp. 345-351
Authors:
Emmanuel, NP
Ware, MR
Brawman-Mintzer, O
Ballenger, JC
Lydiard, RB
Citation: Np. Emmanuel et al., Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder, J CLIN PSY, 60(5), 1999, pp. 299-301
Authors:
Michelson, D
Pollack, M
Lydiard, RB
Tamura, R
Tepner, R
Tollefson, G
Citation: D. Michelson et al., Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine, BR J PSYCHI, 174, 1999, pp. 213-218
Authors:
Pande, AC
Greiner, M
Adams, JB
Lydiard, RB
Pierce, MW
Citation: Ac. Pande et al., Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder, BIOL PSYCHI, 46(6), 1999, pp. 860-862
Authors:
Rubey, RN
Lydiard, RB
Citation: Rn. Rubey et Rb. Lydiard, Management of adverse effects of anxiolytics, MED PSYCH, 12, 1999, pp. 145-168
Authors:
Lydiard, RB
Citation: Rb. Lydiard, The role of drug therapy in social phobia, J AFFECT D, 50, 1998, pp. S35-S39
Authors:
Lydiard, RB
Steiner, M
Burnham, D
Gergel, I
Citation: Rb. Lydiard et al., Efficacy studies of paroxetine in panic disorder, PSYCHOPH B, 34(2), 1998, pp. 175-182